Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease
Abstract Gait issues in Parkinson’s disease (PD) are common and can be highly disabling. Although levodopa and deep brain stimulation (DBS) of the subthalamic nucleus and the globus pallidus internus have been established therapies for addressing the motor symptoms of PD, their effects on gait are l...
Main Authors: | Rubens Gisbert Cury, Nicola Pavese, Tipu Z. Aziz, Joachim K. Krauss, Elena Moro, the Neuromodulation of Gait Study Group from Movement Disorders Society |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00276-6 |
Similar Items
-
Neuromodulation for Gait symptoms in PD: Results from a Network Meta-Analysis
by: V. Hvingelby, et al.
Published: (2022-01-01) -
Neuromodulation for Intractable Pain
by: Alexander L. Green, et al.
Published: (2020-04-01) -
The Use of Neuromodulation for Symptom Management
by: Sarah Marie Farrell, et al.
Published: (2019-09-01) -
Exoskeleton gait training with spinal cord neuromodulation
by: Yury Ivanenko, et al.
Published: (2023-05-01) -
Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease
by: Chioma Anidi, et al.
Published: (2018-12-01)